Metamucil Therapy for Regularity

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Metamucil Therapy for Regularity
Generic name
PSYLLIUM HUSK
Manufacturer
The Procter & Gamble Manufacturing Company
Product type
HUMAN OTC DRUG
SPL set ID
12d030b0-df97-4dd6-88ba-e9fe863c95ea
SPL ID
5ce0fb77-311f-8232-e063-6394a90aacb1
Version
22
Effective date
2026-10-02
Source export date
2026-11-13
Source partition
10
Source file
https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/829e43b83940afb8dda22d5287c5b17e57d3fe45d1157678854b4f9b7ad07271/drug-label-0010-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 17:15:31
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Choking: Taking this product without adequate fluid may cause it to swell and block your throat or esophagus andmay cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention. ALLERGY ALERT: This product may cause allergic reactions in people sensitive to inhaled or ingested psyllium.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.